A carregar...
NT-34 COMPLETE RESPONSE TO VEMURAFINIB IN A PATIENT WITH METASTATIC ANAPLASTIC XANTHROASTROCYTOMA
INTRODUCTION: Approximately 70% of pleomorphic xanthroastrocytomas(PXA) harbor the BRAF-V600E mutation.Vemurafinib has demonstrated activity in melanoma patients with the mutation, but variable activity in other tumors. We report complete response to vemurafanib in a patient with metastatic, anaplas...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4218443/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou265.32 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|